These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 27790946)

  • 21. Lipid Nanoparticles and Active Natural Compounds: A Perfect Combination for Pharmaceutical Applications.
    Puglia C; Pignatello R; Fuochi V; Furneri PM; Lauro MR; Santonocito D; Cortesi R; Esposito E
    Curr Med Chem; 2019; 26(24):4681-4696. PubMed ID: 31203795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transdermal drug delivery: past progress, current status, and future prospects.
    Langer R
    Adv Drug Deliv Rev; 2004 Mar; 56(5):557-8. PubMed ID: 15019745
    [No Abstract]   [Full Text] [Related]  

  • 23. Nasal-to-CNS drug delivery: where are we now and where are we heading? An industrial perspective.
    Landis MS; Boyden T; Pegg S
    Ther Deliv; 2012 Feb; 3(2):195-208. PubMed ID: 22834197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chitosan nanoparticles for oral drug and gene delivery.
    Bowman K; Leong KW
    Int J Nanomedicine; 2006; 1(2):117-28. PubMed ID: 17722528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surface modification and local orientations of surface molecules in nanotherapeutics.
    Amin ML; Joo JY; Yi DK; An SS
    J Control Release; 2015 Jun; 207():131-42. PubMed ID: 25883030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Applications and limitations of lipid nanoparticles in dermal and transdermal drug delivery via the follicular route.
    Lauterbach A; Müller-Goymann CC
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):152-63. PubMed ID: 26144664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanostructure-mediated drug delivery.
    Hughes GA
    Nanomedicine; 2005 Mar; 1(1):22-30. PubMed ID: 17292054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advances in lipid-based colloid systems as drug carrier for topic delivery.
    Zhai Y; Zhai G
    J Control Release; 2014 Nov; 193():90-9. PubMed ID: 24939745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles.
    Reis CP; Neufeld RJ; Ribeiro AJ; Veiga F
    Nanomedicine; 2006 Mar; 2(1):8-21. PubMed ID: 17292111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent Patents, Formulation and Characterization of Nanoliposomes.
    Rohilla S; Dureja H
    Recent Pat Drug Deliv Formul; 2015; 9(3):213-24. PubMed ID: 26118425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interview with Richard H Guy by Hannah Coaker.
    Guy RH
    Ther Deliv; 2014 Feb; 5(2):123-8. PubMed ID: 24483191
    [No Abstract]   [Full Text] [Related]  

  • 32. Peptides for specific intracellular delivery and targeting of nanoparticles: implications for developing nanoparticle-mediated drug delivery.
    Delehanty JB; Boeneman K; Bradburne CE; Robertson K; Bongard JE; Medintz IL
    Ther Deliv; 2010 Sep; 1(3):411-33. PubMed ID: 22816144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of nanotechnology in pharmaceutical product development.
    Devalapally H; Chakilam A; Amiji MM
    J Pharm Sci; 2007 Oct; 96(10):2547-65. PubMed ID: 17688284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanosized particulate systems for dermal and transdermal delivery.
    Hassan AO; Elshafeey AH
    J Biomed Nanotechnol; 2010 Dec; 6(6):621-33. PubMed ID: 21361126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravesical drug delivery: Challenges, current status, opportunities and novel strategies.
    GuhaSarkar S; Banerjee R
    J Control Release; 2010 Dec; 148(2):147-59. PubMed ID: 20831887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breaking the skin barrier.
    Mitragotri S
    Adv Drug Deliv Rev; 2004 Mar; 56(5):555-6. PubMed ID: 15019744
    [No Abstract]   [Full Text] [Related]  

  • 37. Influence of nanocarrier type and size on skin delivery of hydrophilic agents.
    Küchler S; Abdel-Mottaleb M; Lamprecht A; Radowski MR; Haag R; Schäfer-Korting M
    Int J Pharm; 2009 Jul; 377(1-2):169-72. PubMed ID: 19439166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamics and control of percutaneous drug absorption in the presence of epidermal turnover.
    Simon L; Goyal A
    J Pharm Sci; 2009 Jan; 98(1):187-204. PubMed ID: 18481307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanostructured lipid carriers and their current application in targeted drug delivery.
    Jaiswal P; Gidwani B; Vyas A
    Artif Cells Nanomed Biotechnol; 2016; 44(1):27-40. PubMed ID: 24813223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of complexes formation between drugs and penetration enhancers in transdermal delivery.
    Drakulić BJ; Juranić IO; Erić S; Zloh M
    Int J Pharm; 2008 Nov; 363(1-2):40-9. PubMed ID: 18675333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.